Drug General Information
Drug ID
D0K2ZF
Former ID
DNCL002815
Drug Name
PH-797804
Drug Type
Small molecular drug
Indication Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] Phase 2 [522162], [542762]
Company
Pfizer
Structure
Download
2D MOL

3D MOL

Formula
C22H19BrF2N2O3
InChI
InChI=1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28)
InChIKey
KCAJXIDMCNPGHZ-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
References
Ref 522162ClinicalTrials.gov (NCT00559910) A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).. U.S. National Institutes of Health.
Ref 542762(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7818).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.